GeoVax Labs, Inc. (GOVX)
Total Valuation
GeoVax Labs has a market cap or net worth of $4.02 million. The enterprise value is -$2.43 million.
Market Cap | 4.02M |
Enterprise Value | -2.43M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, after market close.
Earnings Date | May 2, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GeoVax Labs has 2.17 million shares outstanding. The number of shares has increased by 60.60% in one year.
Shares Outstanding | 2.17M |
Shares Change (YoY) | +60.60% |
Shares Change (QoQ) | +11.92% |
Owned by Insiders (%) | 1.69% |
Owned by Institutions (%) | 15.73% |
Float | 1.89M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 10.63 |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.70 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with zero debt.
Current Ratio | 2.24 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -189.20% and return on invested capital (ROIC) is -464.02%.
Return on Equity (ROE) | -189.20% |
Return on Assets (ROA) | -140.10% |
Return on Capital (ROIC) | -464.02% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.53M |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.07% in the last 52 weeks. The beta is 2.93, so GeoVax Labs's price volatility has been higher than the market average.
Beta (1Y) | 2.93 |
52-Week Price Change | -79.07% |
50-Day Moving Average | 2.66 |
200-Day Moving Average | 6.38 |
Relative Strength Index (RSI) | 40.09 |
Average Volume (30 Days) | 39,928 |
Short Selling Information
The latest short interest is 16,561, so 0.76% of the outstanding shares have been sold short.
Short Interest | 16,561 |
Short Previous Month | 33,556 |
Short % of Shares Out | 0.76% |
Short % of Float | 0.87% |
Short Ratio (days to cover) | 0.35 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -26.74M |
Pretax Income | -25.97M |
Net Income | -25.97M |
EBITDA | -25.89M |
EBIT | -25.97M |
Earnings Per Share (EPS) | -$14.29 |
Balance Sheet
The company has $6.45 million in cash and no debt, giving a net cash position of $6.45 million or $2.97 per share.
Cash & Cash Equivalents | 6.45M |
Total Debt | n/a |
Net Cash | 6.45M |
Net Cash Per Share | $2.97 |
Equity / Book Value | 5.76M |
Book Value Per Share | 2.65 |
Working Capital | 4.37M |
Cash Flow
In the last 12 months, operating cash flow was -$25.17 million and capital expenditures -$48,946, giving a free cash flow of -$25.22 million.
Operating Cash Flow | -25.17M |
Capital Expenditures | -48,946 |
Free Cash Flow | -25.22M |
FCF Per Share | -$13.88 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GeoVax Labs does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -60.60% |
Shareholder Yield | -60.60% |
Earnings Yield | -646.14% |
FCF Yield | -627.62% |
Analyst Forecast
The average price target for GeoVax Labs is $105.00, which is 5,284.62% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $105.00 |
Price Target Difference | 5,284.62% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 31, 2024. It was a reverse split with a ratio of 1:15.
Last Split Date | Jan 31, 2024 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |